VIM and intrahepatic cholangiocarcinoma: In a previous paper, we reported vimentin expression in intrahepatic cholangiocarcinoma using immunohistochemistry on tissue microarrays (TMA), whereas the 19 HCC included in these TMA were all negative [28].